1. Home
  2. WKEY vs COCP Comparison

WKEY vs COCP Comparison

Compare WKEY & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WISeKey International Holding Ltd

WKEY

WISeKey International Holding Ltd

N/A

Current Price

$8.89

Market Cap

98.4M

Sector

Technology

ML Signal

N/A

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

N/A

Current Price

$0.98

Market Cap

13.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WKEY
COCP
Founded
1999
2006
Country
Switzerland
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.4M
13.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WKEY
COCP
Price
$8.89
$0.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$10.50
$6.00
AVG Volume (30 Days)
293.6K
54.0K
Earning Date
09-23-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,994,000.00
N/A
Revenue This Year
$32.29
N/A
Revenue Next Year
$89.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.90
52 Week High
$19.80
$3.26

Technical Indicators

Market Signals
Indicator
WKEY
COCP
Relative Strength Index (RSI) 49.54 41.93
Support Level $7.31 $0.96
Resistance Level $10.03 $1.05
Average True Range (ATR) 0.79 0.05
MACD 0.12 -0.00
Stochastic Oscillator 54.03 12.91

Price Performance

Historical Comparison
WKEY
COCP

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: